FindTrial
Sign In

Screening - diagnosis - assessment of neonatal congenital heart disease based on remote intelligent auscultation

Screening - diagnosis - assessment of neonatal congenital heart disease based on remote intelligent auscultation

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000035981
Enrollment
Unknown
Registered
2020-08-21
Start date
2020-08-20
Completion date
Unknown
Last updated
2020-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congenital heart disease

Interventions

Gold Standard:Cardiac echography
Index test:Intelligent&#32
diagnosis&#32
of&#32
neonatal&#32
congenital&#32
heart&#32
disease&#32
based&#32
on&#32
remote&#32
intelligent&#32
auscultation.

Sponsors

Shanghai Children's Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: Newborns born after 0: 00 on July 1, 2019 and born before 24: 00 on December 31, 2021.

Exclusion criteria

Exclusion criteria: Patients diagnosed as congenital heart disease by fetal ultrasound.

Design outcomes

Primary

MeasureTime frame
oxygen saturation;heart sound auscultation;Face photos or videos;SEN, SPE, ACC, AUC of ROC, PPV, NPV, etc.;—

Countries

China

Contacts

Public ContactShi Guocheng

Shanghai Children's Medical Center

shiguocheng@scmc.com.cn+86 18817798769

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026